Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SEVERITY LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 EMERGING TREATMENTS FOR HUNTER SYNDROME
5.1 TREATMENT: DNL310
5.2 TREATMENT: JR141
5.3 TREATMENT: TAK-609/SHP609/HGT-2310
5.4 TREATMENT: RGX-121
5.5 TREATMENT: SB-913
5.6 TREATMENT: AVR-RD-05
5.7 TREATMENT: ODIPARCIL
5.8 TREATMENT: AGT-181
5.9 TREATMENT: EGT-301
6 REGULATORY GUIDELINES FOR HUNTER SYNDROME (MPS II)
6.1 U.S REGULATORY FRAMEWORK FOR HUNTER SYNDROME
6.2 EUROPE REGULATORY FRAMEWORK FOR HUNTER SYNDROME
6.3 ASIA-PACIFIC REGULATORY FRAMEWORK FOR HUNTER SYNDROME
7 EPIDEMIOLOGY
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASING PREVALENCE OF HUNTER SYNDROME
8.1.2 RISING ADOPTION OF GENE THERAPY
8.1.3 INCREASING GOVERNMENT INITIATIVES
8.1.4 INCREASING FUND BY PUBLIC AND PRIVATE ORGANISATIONS
8.1.5 TECHNOLOGICAL ADVANCEMENTS
8.2 RESTRAINTS
8.2.1 ADVERSE EFFECTS OF CURRENT TREATMENTS
8.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MPS II TREATMENT DEVELOPMENT
8.2.3 UNAWARENESS AMONG PEOPLE OF THE EXISTENCE OF HUNTER SYNDROME
8.2.4 HIGH COST ASSOCIATED WITH TREATMENT OF MPS II
8.3 OPPORTUNITIES
8.3.1 HIGH DEMAND OF DISEASE-SPECIFIC TREATMENT
8.3.2 RISING COLLABORATIONS, AND MERGERS & ACQUISITIONS AMONG THE MARKET PLAYERS
8.3.3 PRESENCE OF NOVEL PIPELINE DRUGS
8.4 CHALLENGES
8.4.1 LIMITATIONS OF CURRENT TREATMENT
8.5 IMPROPER REIMBURSEMENT POLICIES
9 IMPACT OF COVID-19 ON THE ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET
9.1 IMPACT ON PRICE
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY CHAIN
9.4 STRATEGIC DECISIONS FOR MANUFACTURERS
9.5 CONCLUSION
10 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY
10.1 OVERVIEW
10.2 MODERATE TO SEVERE
10.3 MILD TO MODERATE
11 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY TYPE
11.1 OVERVIEW
11.2 ENZYME REPLACEMENT THERAPY
11.2.1 ELAPRASE + TAK-609
11.2.2 HUNTERASE
11.2.3 IZCARGO
11.3 STEM CELL TRANSPLANT
11.3.1 UMBILICAL CORD TRANSPLANT
11.3.2 BONE MARROW TRANSPLANT
11.4 SURGICAL TREATMENT
11.4.1 CARDIAC VALVE REPLACEMENT SURGERY
11.4.2 TRACHEOSTOMY
11.4.3 POSITIVE AIRWAY PRESSURE DEVICES
11.4.4 JOINT CONTRACTURES
11.4.5 ABDOMINAL HERNIA SURGERY
11.4.6 OTHERS
11.5 OTHERS
12 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS
12.1 OVERVIEW
12.2 RESPIRATORY DISORDERS
12.3 NEUROLOGICAL DISORDERS
12.4 CARDIOVASCULAR
12.5 MUSCULOSKELETAL
12.6 GASTROINTESTINAL DISORDERS
12.7 OPHTHALMIC
12.8 AUDIOLOGIC
12.9 DENTAL
12.1 OTHERS
13 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 CLINICS
13.4 HOME HEALTHCARE
13.5 OTHERS
14 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 HOSPITAL PHARMACY
14.3 RETAIL PHARMACY
14.4 ONLINE PHARMACY
14.5 OTHERS
15 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY REGION
15.1 ASIA-PACIFIC
15.1.1 JAPAN
15.1.2 SOUTH KOREA
15.1.3 CHINA
15.1.4 INDIA
15.1.5 AUSTRALIA
15.1.6 SINGAPORE
15.1.7 MALAYSIA
15.1.8 THAILAND
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 VIETNAM
15.1.12 REST OF ASIA-PACIFIC
16 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 TAKEDA PHARMACEUTICAL COMPANY LIMITED
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 GREEN CROSS CORP.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENT
18.3 ABBOTT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 PRODUCT PORTFOLIO
18.3.4 RECENT DEVELOPMENTS
18.4 AVROBIO, INC.
18.4.1 COMPANY SNAPSHOT
18.4.2 PRODUCT PORTFOLIO
18.4.3 RECENT DEVELOPMENTS
18.5 BD
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENT
18.6 CANBRIDGE LIFE SCIENCES LTD.
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 DENALI THERAPEUTICS
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENTS
18.8 HOMOLOGY MEDICINES, INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 REVENUE ANALYSIS
18.8.3 TECHNOLOGY PORTFOLIO
18.8.4 RECENT DEVELOPMENTS
18.9 INVENTIVA
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 PRODUCT PORTFOLIO
18.9.4 RECENT DEVELOPMENTS
18.1 JASPER THERAPEUTICS, INC.
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 JCR PHARMACEUTICALS CO., LTD.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 JOHNSON & JOHNSONS SERVICES, INC.
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENTS
18.13 MEDTRONIC
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 NOVARTIS AG
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENTS
18.15 ON-X LIFE TECHNOLOGIES (A SUBSIDIARY OF CRYOLIFE, INC.)
18.15.1 COMPANY SNAPSHOT
18.15.2 REVENUE ANALYSIS
18.15.3 PRODUCT PORTFOLIO
18.15.4 RECENT DEVELOPMENTS
18.16 PFIZER INC.
18.16.1 COMPANY SNAPSHOT
18.16.2 REVENUE ANALYSIS
18.16.3 PRODUCT PORTFOLIO
18.16.4 RECENT DEVELOPMENTS
18.17 REGENXBIO INC.
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 PRODUCT PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.18 SANGAMO THERAPEUTICS
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 STRYKER
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.2 UCB S.A.
18.20.1 COMPANY SNAPSHOT
18.20.2 REVENUE ANALYSIS
18.20.3 PRODUCT PORTFOLIO
18.20.4 RECENT DEVELOPMENTS
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 2 ASIA-PACIFIC MODERATE TO SEVERE IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 ASIA-PACIFIC MILD TO MODERATE IN ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC RESPIRATORY DISORDERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC NEUROLOGICAL DISORDERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC CARDIOVASCULAR IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC MUSCULOSKELETAL IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC GASTROINTESTINAL DISORDERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC OPHTHALMIC IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC AUDIOLOGIC IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC DENTAL IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: BY END USER, 2020
TABLE 23 ASIA-PACIFIC HOSPITALS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC CLINICS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC HOME HEALTHCARE IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020
TABLE 28 ASIA-PACIFIC HOSPITAL PHARMACY IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC RETAIL PHARMACY IN HUNTER SYNDROME MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC ONLINE PHARMACY IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC OTHERS IN HUNTER SYNDROME TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 JAPAN HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 42 JAPAN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 43 JAPAN ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 44 JAPAN STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 45 JAPAN SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 JAPAN HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 47 JAPAN HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 48 JAPAN HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 49 SOUTH KOREA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 50 SOUTH KOREA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 51 SOUTH KOREA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 52 SOUTH KOREA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 53 SOUTH KOREA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 54 SOUTH KOREA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 55 SOUTH KOREA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 56 SOUTH KOREA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 57 CHINA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 58 CHINA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 CHINA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 60 CHINA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 CHINA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 62 CHINA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 63 CHINA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 64 CHINA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 65 INDIA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 66 INDIA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 67 INDIA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 INDIA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 INDIA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 70 INDIA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 71 INDIA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 72 INDIA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 73 AUSTRALIA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 74 AUSTRALIA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 75 AUSTRALIA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 76 AUSTRALIA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 77 AUSTRALIA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 AUSTRALIA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 79 AUSTRALIA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 80 AUSTRALIA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 SINGAPORE HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 82 SINGAPORE HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 83 SINGAPORE ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 84 SINGAPORE STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 SINGAPORE SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 SINGAPORE HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 87 SINGAPORE HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 88 SINGAPORE HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 89 MALAYSIA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 90 MALAYSIA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 91 MALAYSIA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 92 MALAYSIA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 93 MALAYSIA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 94 MALAYSIA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 95 MALAYSIA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 96 MALAYSIA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 97 THAILAND HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 98 THAILAND HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 99 THAILAND ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 THAILAND STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 101 THAILAND SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 102 THAILAND HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 103 THAILAND HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 104 THAILAND HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 105 INDONESIA HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 106 INDONESIA HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 INDONESIA ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 108 INDONESIA STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 109 INDONESIA SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 110 INDONESIA HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 111 INDONESIA HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 112 INDONESIA HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 113 PHILIPPINES HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 114 PHILIPPINES HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 115 PHILIPPINES ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 116 PHILIPPINES STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 117 PHILIPPINES SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 118 PHILIPPINES HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 119 PHILIPPINES HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 120 PHILIPPINES HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 121 VIETNAM HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 122 VIETNAM HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 123 VIETNAM ENZYME REPLACEMENT THERAPY (ERT) IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 124 VIETNAM STEM CELL TRANSPLANT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 125 VIETNAM SURGICAL TREATMENT IN HUNTER SYNDROME TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 126 VIETNAM HUNTER SYNDROME TREATMENT MARKET, BY COMPLICATIONS, 2019-2028 (USD MILLION)
TABLE 127 VIETNAM HUNTER SYNDROME TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 128 VIETNAM HUNTER SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 129 REST OF ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : SEGMENTATION
FIGURE 2 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : MARKET END USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET : SEGMENTATION
FIGURE 11 INCREASING PREVALANCE OF HUNTER SYNDROME IS EXPECTED TO DRIVE THE ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 MODERATE TO SEVERE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET
FIGURE 14 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: BY SEVERITY, 2020
FIGURE 17 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: BY END USER, 2020
FIGURE 18 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 19 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: SNAPSHOT (2020)
FIGURE 20 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: BY COUNTRY (2020)
FIGURE 21 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 22 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 23 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: BY SEVERITY (2021-2028)
FIGURE 24 ASIA-PACIFIC HUNTER SYNDROME TREATMENT MARKET: COMPANY SHARE 2020 (%)
